Locust Wood Capital Advisers Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$29.2M |
| 2 |
S&P Global
SPGI
|
+$26.5M |
| 3 |
Steris
STE
|
+$23.2M |
| 4 |
PG&E
PCG
|
+$17.4M |
| 5 |
Abbott
ABT
|
+$14.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$31.8M |
| 2 |
Amazon
AMZN
|
+$19M |
| 3 |
Linde
LIN
|
+$16.3M |
| 4 |
UnitedHealth
UNH
|
+$15.4M |
| 5 |
Waste Management
WM
|
+$9.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.3% |
| 2 | Industrials | 14.8% |
| 3 | Technology | 11.26% |
| 4 | Healthcare | 10.68% |
| 5 | Materials | 10.36% |
Similar funds
Locust Wood Capital Advisers's Q2 2022 Portfolio in Review
As of Q2 2022, Locust Wood Capital Advisers held 51 positions worth $1.62B, down 11% from $1.82B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Locust Wood Capital Advisers deployed $72.8M of net new capital in Q2 2022, opening 7 new positions and adding to 21 existing holdings. Its largest new stake was Steris: 103,028 shares worth $21.2M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Elevance Health, an estimated $31.8M trimmed.
- Locust Wood Capital Advisers's largest Q2 2022 buy was Steris: 103,028 shares worth $21.2M.
- Locust Wood Capital Advisers added most to TSMC in Q2 2022, an estimated $29.2M increase.
- Locust Wood Capital Advisers's biggest Q2 2022 reduction was Elevance Health, cutting an estimated $31.8M.
- Locust Wood Capital Advisers's ten largest holdings make up 48% of its $1.62B portfolio in Q2 2022.
- Locust Wood Capital Advisers opened 7 new positions and closed 3 in Q2 2022.
- Locust Wood Capital Advisers's portfolio value fell 11% quarter-over-quarter to $1.62B.
Based on Locust Wood Capital Advisers's 13F filing for Q2 2022, filed 20 Jul 2022.